文献速递病毒性肝炎医院感染防控

澳大利亚新南威尔士州近期药物依赖住院者丙肝治疗衔接机会:基于人群的 linkage 研究

Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study.
PubMed 文献 · Clin Infect Dis · 2021-01-01

结果显示 26% 有近期药物依赖证据,其中 50% 在 DAA eligible 期间住院,但频繁住院者 DAA 治疗率最低。

要点

  • 近期药物依赖的 HCV 感染者中 50% 在 DAA eligible 期间住院。
  • 精神健康、药物相关和注射相关感染住院发生率最高。
  • 住院≥2次、≥7天者 DAA 治疗 uptake 最低。

核心结论

  • 近期药物依赖者频繁住院(尤其精神健康、药物和酒精相关入院)为衔接 HCV 治疗提供了机会。

主要发现

  • 有近期药物依赖者中 50%(n=7506)在 DAA eligible 期间住院。
  • 选定病因住院发生率最高为精神健康相关(15.84/100 PY)、药物相关(15.20/100 PY)、注射相关感染病(9.15/100 PY)。
  • 住院者中 65%(n=4898)入院≥2次,46%(n=3437)住院≥7天。

关键数值与推荐

  • 截至2018年底,DAA 治疗率在住院≥2次、住院≥7天者中最低。
  • DAA 治疗率在首次入院原因为注射相关感染病、精神健康障碍和药物相关并发症者中最低。

临床怎么用

  • 对近期药物依赖的 HCV 感染者,尤其因精神健康、药物或酒精相关原因频繁住院者,应在住院期间主动衔接 HCV 治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People who inject drugs are at greater risk of hepatitis C virus (HCV) infection and hospitalization, yet admissions are not utilized for HCV treatment initiation. We aimed to assess the extent to which people with HCV notification, including those with evidence of recent drug dependence, are hospitalized while eligible for direct-acting antiviral (DAA) therapy, and treatment uptake according to hospitalization in the DAA era. METHODS: We conducted a longitudinal, population-based cohort study of people living with HCV in the DAA era (March 2016-December 2018) through analysis of linked databases in New South Wales, Australia. Kaplan-Meier estimates were used to report HCV treatment uptake by frequency, length, and cause-specific hospitalization. RESULTS: Among 57 467 people, 14 938 (26%) had evidence of recent drug dependence, 50% (n = 7506) of whom were hospitalized while DAA eligible. Incidence of selected cause-specific hospitalization was highest for mental health-related (15.84 per 100 person-years [PY]), drug-related (15.20 per 100 PY), and injection-related infectious disease (9.15 per 100 PY) hospitalizations, and lowest for alcohol use disorder (4.58 per 100 PY) and liver-related (3.13 per 100 PY). In total, 65% (n = 4898) of those who were hospitalized had been admitted ≥2 times, and 46% (n = 3437) were hospitalized ≥7 days. By the end of 2018, DAA therapy was lowest for those hospitalized ≥2 times, for ≥7 days, and those whose first admission was for injection-related infectious disease, mental health disorders, and drug-related complications. CONCLUSIONS: Among people who have evidence of recent drug dependence, frequent hospitalization-particularly mental health, drug, and alcohol admissions-presents an opportunity for engagement in HCV care.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Valerio H, Alavi M, Law M, et al. Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study. Clin Infect Dis. 2021. PMID: 34107022. doi:10.1093/cid/ciab526

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。